Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 50 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

5%

1 of 20 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

40Total
Not Applicable (31)
P 1 (2)
P 2 (5)
P 3 (2)

Trial Status

Completed20
Unknown16
Recruiting8
Not Yet Recruiting3
Active Not Recruiting2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 20 completed trials

Clinical Trials (50)

Showing 20 of 20 trials
NCT05890534Phase 3CompletedPrimary

Pycnogenol® in Post-COVID-19 Condition

NCT05677932Not ApplicableCompletedPrimary

Bright Light Therapy for Post-COVID-19 Fatigue

NCT06082518Not ApplicableRecruitingPrimary

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

NCT05532904Not ApplicableCompletedPrimary

Multidisciplinary Day-hospital Versus Waiting List Management of Post-COVID-19 Persistent Symptoms (ECHAP-COVID)

NCT07110714Not ApplicableRecruitingPrimary

Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients

NCT05240742Completed

CORona (COVID-19) Follow Up Study: Epidemiology, Pathophysiology, Prediction, and Communication

NCT06928506Not ApplicableRecruiting

Effect of Hi-OxSR for the Treatment of Post COVID Condition

NCT06865222Not ApplicableRecruitingPrimary

Post COVID-19 Syndrome Treatment With Variable Pulse Transcranial Magnetic Stimulation

NCT05167227Not ApplicableActive Not Recruiting

Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?

NCT06156176Not ApplicableRecruiting

Pursuing Reduction in Fatigue After COVID-19 Via Exercise and Rehabilitation (PREFACER): A Randomized Feasibility Trial

NCT05841498Not ApplicableCompleted

Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome

NCT05866952Recruiting

Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection

NCT06251518Not ApplicableActive Not Recruiting

Investigating the Effectiveness of Vimida

NCT05682560Phase 2Completed

Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome

NCT05638620Phase 1Completed

Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID

NCT06766825Phase 2RecruitingPrimary

Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC)

NCT05592418Phase 2CompletedPrimary

Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions

NCT05877534Not ApplicableEnrolling By Invitation

Effects of Individual Tailored Physical Exercise in Patients With POTS After COVID-19 - a Randomized Controlled Study

NCT05823896Phase 2Completed

ImPROving Quality of LIFe in the Long COVID Patient

NCT06679218Not ApplicableNot Yet RecruitingPrimary

Improving Health Status in COVID-19 Long-Hauler

Scroll to load more

Research Network

Activity Timeline